{
    "Trade/Device Name(s)": [
        "BioPlex 2200 Syphilis IgG kit",
        "BioPlex 2200 Syphilis IgG on the BioPlex 2200 Multi-Analyte Detection System"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K063866",
    "Predicate Device Reference 510(k) Number(s)": [
        "Pre-Amendment",
        "971502",
        "001552"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIP"
    ],
    "Summary Letter Date": "March 8, 2007",
    "Summary Letter Received Date": "March 9, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "Treponema pallidum IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Defibrinated plasma tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BioPlex 2200 Multi-Analyte Detection System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay",
        "Fluorescence-based detection"
    ],
    "Methodologies": [
        "Flow immunoassay",
        "Multiplex bead technology"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control",
        "Instrument",
        "Software",
        "System",
        "Buffer",
        "Wash solution"
    ],
    "Document Summary": "FDA 510(k) summary for BioPlex 2200 Syphilis IgG kit, a multiplex flow immunoassay for qualitative detection of Treponema pallidum IgG antibodies in human serum.",
    "Indications for Use Summary": "Qualitative detection of Treponema pallidum IgG antibodies in human serum; used in conjunction with non-treponemal assays for evidence of infection and to confirm reactive results from non-treponemal screening assays.",
    "fda_folder": "Microbiology"
}